Loading 3B Blackbio Dx…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 33 | 35 | 50 | 34 | 22 |
| Operating profit | 7 | 5 | 21 | 14 | 12 |
| Operating margin | 21.4% | 13.0% | 41.6% | 41.7% | 52.0% |
| Net profit | 10 | 10 | 22 | 15 | 13 |
| Net margin | 28.5% | 27.0% | 43.2% | 43.4% | 56.6% |
| EPS (₹) | 11.11 | 11.44 | 25.32 | 17.55 | 14.67 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 142 | 96 | 74 | 62 |
| Operating profit | 55 | 49 | 32 | 29 |
| Operating margin | 38.9% | 51.1% | 43.1% | 46.3% |
| Net profit | 60 | 48 | 33 | 26 |
| Net margin | 42.2% | 49.4% | 44.2% | 41.9% |
| EPS (₹) | 69.94 | 55.66 | 37.46 | 30.27 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 378 | 296 | 248 | 214 |
| Total liabilities | 46 | 25 | 23 | 18 |
| Shareholders’ equity | 324 | 268 | 223 | 193 |
| Total debt | 5 | 0 | 1 | 2 |
| Cash & equivalents | 38 | 12 | 13 | 5 |
| Debt / equity | 0.01 | 0.00 | 0.00 | 0.01 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 52 | 43 | 27 | 20 |
| Capital expenditure | -26 | -1 | -1 | -2 |
| Free cash flow | 27 | 42 | 26 | 18 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 18.5% | 17.8% | 14.7% | 13.4% |
| Return on assets | 15.9% | 16.1% | 13.2% | 12.1% |
| Net margin | 42.2% | 49.4% | 44.2% | 41.9% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for 3BBLACKBIO. Finnhub coverage is limited for some India-listed stocks.